Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shared genetic regulators and diagnostic biomarkers in gallbladder stone and cholangiocarcinoma: A comprehensive comparative transcriptomic analysis.

Translational oncology·2026
Same author

Pituitary adenylate cyclase-activating polypeptide attenuates coronary microembolization-induced myocardial apoptosis via PAC1 receptor activation in rats.

Tissue & cell·2026
Same author

Dispersion Compensation and Multi-Beam Interference Correction Algorithm for Thickness Measurement of SiC Epitaxial Layer.

Sensors (Basel, Switzerland)·2026
Same author

Structure and druggable conformation of the homodimeric lipoprotein transporter of Acinetobacter baumannii.

Nature communications·2026
Same author

High-Performance Water Purification and Synergistic Hydrovoltaic by Avocado Peels Decorated With Carbon Dots.

Small science·2026
Same author

Study on the anti-pulmonary fibrosis mechanism of Renshen Pingfei formula by inhibiting M2 macrophage polarization and regulating TGF - β/SMAD signaling pathway.

Journal of ethnopharmacology·2026

Related Experiment Video

Updated: May 25, 2026

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

Endogenous cardioprotection by ischaemic postconditioning and remote conditioning.

Weiwei Shi1, Jakob Vinten-Johansen

  • 1Department of Surgery, Emory University School of Medicine, Atlanta, GA 30308-2225, USA.

Cardiovascular Research
|February 11, 2012
PubMed
Summary

Heart conditioning, using brief ischemia/reperfusion, protects against cell death from myocardial infarction. Remote organ conditioning offers a safer alternative, with ongoing research for clinical application.

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

Related Experiment Videos

Last Updated: May 25, 2026

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents
07:52

Remote Limb Ischemic Preconditioning: A Neuroprotective Technique in Rodents

Published on: June 2, 2015

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

Area of Science:

  • Cardiovascular Science
  • Cellular Biology
  • Molecular Medicine

Background:

  • Persistent myocardial ischemia leads to cell death if not treated with reperfusion.
  • Evolutionary protective responses, termed 'conditioning,' can adapt tissues to stressors like ischemia-reperfusion injury.
  • Conditioning strategies are being explored to mitigate myocardial ischemia and reperfusion damage.

Purpose of the Study:

  • To review the mechanisms and applications of cardiac conditioning in protecting the heart from ischemia-reperfusion injury.
  • To explore the potential of remote organ conditioning as a therapeutic strategy.
  • To identify areas for future research and clinical translation.

Main Methods:

  • Review of existing literature on preconditioning, perconditioning, and postconditioning.
  • Analysis of molecular and physiological pathways involved in cardioprotection.
  • Discussion of clinical translation challenges and opportunities.

Main Results:

  • Conditioning, applied before, during, or after ischemia, protects cells by attenuating necrosis and apoptosis.
  • Cardioprotective pathways, potentially converging on mitochondria, are activated or rebalanced.
  • Remote organ conditioning bypasses direct cardiac stress, enhancing therapeutic potential.
  • Pharmacological mimetics are emerging as a therapeutic avenue.

Conclusions:

  • Cardiac conditioning is a promising strategy to protect the heart against ischemia-reperfusion injury.
  • Remote conditioning and pharmacological mimetics represent significant advancements for clinical application.
  • Further research and large-scale clinical trials are necessary for wider adoption in treating myocardial infarction.